| Q39553993 | A randomised, double-blind, placebo-controlled clinical trial of vitamin A in severe malaria in hospitalised Mozambican children |
| Q48030403 | An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children |
| Q35238319 | Antiparasitic chemotherapy: from genomes to mechanisms |
| Q57778306 | Antiprotozoal drugs |
| Q36671618 | Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. |
| Q33908825 | Artemisinin derivatives for treating severe malaria |
| Q34075018 | Artemisinin drugs: novel antimalarial agents |
| Q35521094 | Artemisinins |
| Q35891386 | Chemotherapy of drug-resistant malaria |
| Q35091391 | Clinical features and outcome in children with severe Plasmodium falciparum malaria: a meta-analysis |
| Q41258804 | Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria |
| Q48036893 | Coma scales for children with severe falciparum malaria |
| Q47989638 | Combination chemotherapy for Plasmodium falciparum malaria |
| Q40630628 | Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria |
| Q48034649 | Constituents of Picralima nitida display pronounced inhibitory activities against asexual erythrocytic forms of Plasmodium falciparum in vitro |
| Q36158292 | Efficacy of a novel sublingual spray formulation of artemether in African children with Plasmodium falciparum malaria |
| Q40630864 | In vitro antiplasmodial activity of Central American medicinal plants |
| Q47834678 | Incidence of antimalarial pretreatment and drug sensitivity in vitro in multidrug-resistant Plasmodium falciparum infection in Thailand |
| Q73123859 | Malaria |
| Q33756907 | Neurotoxicity of artemisinin analogs in vitro |
| Q39590009 | Not much progress in treatment of cerebral malaria |
| Q40671285 | Open comparison of artemether and mefloquine in uncomplicated Plasmodium falciparum hyperparasitaemia in children |
| Q41937695 | Pharmacodynamics of antimalarial chemotherapy |
| Q35802479 | Pharmacokinetics of intramuscular artemether in patients with severe falciparum malaria with or without acute renal failure |
| Q48009973 | Progress in the research of artemisinin-related antimalarials: an update |
| Q40522405 | Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sufadoxine-pyrimethamine-resistant falciparum malaria during pregnancy |
| Q36886014 | Recent advances in tropical medicine |
| Q33842637 | Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial |
| Q48037061 | The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study |
| Q44477861 | Treatment of children with malaria Plasmodium falciparum with derivatives artemisinin |